Mapmygenome In the News: Financial Express June 2, 2015

By BV Mahalakshmi, Financial Express. Read the original article →

Anandan-Backed MapmyGenome Plans to Raise Rs 50–60 Cr in a Year

Hyderabad-based MapmyGenome India — a provider of personal genomics and predictive tests backed by Google India MD Rajan Anandan — is planning to raise about Rs 50–60 crore in the next 12 months. The company is planning to spread the benefits of genome mapping across the country through genetic counsellors, besides scaling up research on predictive diagnostics.

“We recently raised Rs 10 crore, which includes Rs 3 crore from the founders. We are in talks with investors to raise about Rs 50–60 crore in the next 12 months. Currently, we are consolidating our team and optimising the operations process.” — Anu Acharya, CEO, MapmyGenome

“Genetics in healthcare is currently the most-talked-about topic in academia, industry and government. We see a great interest in personal genomics and precision medicine, especially in the US and China. As governments and healthcare providers realise the clinical utility of these tests in preventive healthcare, we are bound to see more interest.” — Anu Acharya

MapmyGenome has created a new market for predictive tests with its flagship brand Genomepatri™. The company has tied up with over 30 hospital networks and has started receiving orders from Singapore and Malaysia.